EUVIMEDEUVIMED entdecken
Crossref

Lysosome-Targeted Iridium(III)-BODIPY Conjugates with GSH-Activatable Reactive Oxygen Species Generation for Enhanced Photodynamic Immunotherapy of Melanoma

Junfeng Zhang, Lingyu Jin, Jia Yang, Shiyu Chen, Xingfen Yu, Fei Zheng, Fengying Yuan, Junfeng Kou iD, Yuda Zhu, Wenxiu Ren

Journal of Medicinal Chemistry · 12.11.2026 · 69 (21) · 25749-25759

DOI: 10.1021/acs.jmedchem.6c01732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 23.10.2026. Verfasst von Junfeng Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Modern Separation Analysis and Substance Transformation, College of Chemistry and Chemical Engineering, Yunnan Normal Univer…. Hauptthemen laut MEDLINE: Iridium, Boron Compounds, Reactive Oxygen Species, Glutathione. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, Major Science and Technology Projects in Yunnan Province, Southwest Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma represents a major clinical challenge due to its aggressive nature, high metastatic potential, and resistance to conventional therapies. Herein, we developed two near-infrared iridium(III)-BODIPY conjugates (BODIPY-1-Ir and BODIPY-2-Ir) for glutathione (GSH)-activated photodynamic immunotherapy. These conjugates function as lysosome-targeting photosensitizers that deplete intracellular GSH to disrupt redox balance and enhance reactive oxygen species generation with light irradiation. The phototoxicity further induces cascading dendritic cell maturation and tumor-associated macrophage reprogramming, promoting immunogenic cell death. Both in vitro and in vivo studies demonstrated their excellent biocompatibility, strong photodynamic anticancer efficiency, and significant tumor growth inhibition, highlighting their potential as promising candidates for melanoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridiumBoron CompoundsReactive Oxygen SpeciesGlutathionePhotochemotherapyPhotosensitizing AgentsLysosomesMelanomaAntineoplastic AgentsAnimalsHumansMiceImmunotherapyCell Line, Tumor

Stichwörter der Autor:innen

glutathione-Activatediridium(III)-BODIPY conjugateslysosome-targetingphotodynamicImmunotherapy

Substanzen

IridiumBoron CompoundsReactive Oxygen Species4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneGlutathionePhotosensitizing AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Yunnan Key Laboratory of Modern Separation Analysis and Substance Transformation, College of Chemistry and Chemical Engineering, Yunnan Normal University, Kunming650500, China.
  • Department of Radiology, The Affiliated Hospital, Southwest Medical University, NO.25, Taiping Road, Jiangyang District, Luzhou646000Sichuan, China.
  • Precision Imaging and Intelligent Analysis Key Laboratory of Luzhou, Southwest Medical University, Luzhou646000Sichuan, China.

ORCID-Profile: Junfeng Kou

Förderung

  • Natural Science Foundation of Sichuan Province
  • Major Science and Technology Projects in Yunnan Province
  • Southwest Medical University
  • National Natural Science Foundation of China (NSFC)
  • Yunnan Province Jong Seung Kim Academician Expert Workstation
  • Applied Basic Research Project by Office of Science and Technology and Talent Work of
  • Applied Basic Research Project by Office of Science and Technology and Talent Work of Luzhou

Zitieren

APA

Zhang, J., Jin, L., Yang, J., Chen, S., Yu, X., Zheng, F., Yuan, F., Kou, J., Zhu, Y., & Ren, W. (2026). Lysosome-Targeted Iridium(III)-BODIPY Conjugates with GSH-Activatable Reactive Oxygen Species Generation for Enhanced Photodynamic Immunotherapy of Melanoma. Journal of Medicinal Chemistry, 69(21), 25749-25759. https://doi.org/10.1021/acs.jmedchem.6c01732

Vancouver

Zhang J, Jin L, Yang J, Chen S, Yu X, Zheng F, et al. Lysosome-Targeted Iridium(III)-BODIPY Conjugates with GSH-Activatable Reactive Oxygen Species Generation for Enhanced Photodynamic Immunotherapy of Melanoma. Journal of Medicinal Chemistry. 2026;69(21):25749-25759. doi:10.1021/acs.jmedchem.6c01732

BibTeX
@article{Zhang2026,
  author = {Zhang, Junfeng and Jin, Lingyu and Yang, Jia and Chen, Shiyu and Yu, Xingfen and Zheng, Fei and Yuan, Fengying and Kou, Junfeng and Zhu, Yuda and Ren, Wenxiu},
  title = {Lysosome-Targeted Iridium(III)-BODIPY Conjugates with GSH-Activatable Reactive Oxygen Species Generation for Enhanced Photodynamic Immunotherapy of Melanoma},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {21},
  pages = {25749--25759},
  doi = {10.1021/acs.jmedchem.6c01732}
}
Kostenlos starten →